Post-doctoral fellowship in functional and high-resolution genomic studies of acute leukemia, Lund University, Sweden.
The Hagström-Andersson research group (1-3), Division of Clinical Genetics, Lund University (4), is announcing a 24-month postdoctoral scholarship with a focus on functional characterization of leukemia-associated genetic changes and high-resolution genomic studies starting in August 2019.
We are looking for a skillful, ambitious and highly motivated postdoc to join the Hagström-Andersson´s research group, Department of Laboratory Medicine, Lund University. The overarching purpose of this project is to unravel the pathogenetic mechanisms involved in hematopoietic cell transformation using a combination of genomic approaches and murine genetic models. More specifically, by using high-resolution genomic studies, also at the single-cell level and in vivo models, our goal is to gain new knowledge on how leukemia arise and best should be treated. The postdoctoral project focus on the functional characterization of leukemia-associated genetic changes using a combination of in vitro work, leukemia mouse models, and high-resolution genomic studies such as RNA-sequencing.
The Hagström-Andersson research group
Our research group performs cutting-edge research recently published in well renowned scientific journals (Nature Genetics, Nature Communications, and Leukemia). All equipment, including advanced cell sorters and next generation sequencing are available, as well as several in vivo experimental models, providing a solid base for our research.
How to apply
Candidates should provide an application referring to Dnr: V2018/2052 along with the following documents:
1) a motivation letter, maximum one page, outlining why you are applying for the fellowship. 2) a curriculum vitae
3) a list of publications
4) PhD Diploma
5) the contact information of at least two references including at least one recommendation letter
Send applications and questions to Anna Hagström-Andersson: firstname.lastname@example.org
We are looking for a highly motivated scientist with a suitable research background. Applicants are expected to have recent first author publications in internationally renowned peer-reviewed journals. Previous experience from research on cancer or hematopoietic malignancies is required and previous experience of animal work, next-generation sequencing or bioinformatics analysis is a merit. The applicant should not have been employed by Lund University within the last two years in order to be able to receive a scholarship. The PhD degree should not be more than three years old at the last day of applying. Applicants close to finishing up their PhD studies are also welcome to apply. Ability to work independently, as well as part of a team is essential.
Lund University offers an impressive range of high-quality research and education, made possible by our 7,400 staff members and 40,000 students. We host one of the leading hematology and cancer research environments in Europe. The environment involves some 300 researchers and students, in close proximity to the University Hospital, and is equipped with multiple technical platforms to support cutting-edge research in cancer.
The scholarship amounts to 25 000 SEK/month (tax-free).
Last day of application is June 1, 2019; start date is August 19 or according to agreement
References and links: